piperazine has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, YY | 1 |
| Shi, LX | 1 |
| Li, JH | 1 |
| Yao, LY | 1 |
| Xiang, DX | 1 |
| Gupta, S | 1 |
| Pandey, G | 1 |
| Rahuja, N | 1 |
| Srivastava, AK | 1 |
| Saxena, AK | 1 |
2 other studies available for piperazine and Alloxan Diabetes
| Article | Year |
|---|---|
Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Ani | 2019 |
Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors.
Topics: Animals; Binding Sites; Catalytic Domain; Computer Simulation; Diabetes Mellitus, Experimental; Dise | 2010 |